FDA Approved: CILOSTAZOL — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA granted a supplemental approval for cilostazol by Chartwell RX, LLC under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Arterial Disease

Drugs mentioned

• Cilostazol (Cilostazol)

Snippet

SUPPL AP for CILOSTAZOL (CILOSTAZOL)